Oncologix Tech, Inc. announced a private placement of a promissory note for gross proceeds of $100,000 with a non-affiliated accredited Investor on July 26, 2013. The company issued an additional 2,500 series D convertible preferred stock in the transaction. The note carries a coupon of 18% per annum and would mature on January 26, 2015.